Research and innovation



To achieve our goal of excellence and be an innovative competitor in our markets,  we are constantly striving to improve the services we offer to our customers.  By listening to their requirements and technological advances, we can develop tools and services adapted to meet the challenges of tomorrow.

The culture of innovation within Staphyt promotes the continuous improvement of our employees’ working comfort, performance,  productivity and responsiveness.



Each year Staphyt invests 10% of its turn-over to maintain a high level of performance in all services. Our experts are involved in national and international working groups and so actively take part to both methodology and regulation reflection and evolution.

In partnership with public and academic institutes, we innovate in setting up new evaluation methods for plant protection and nutrition products.


Interview of Staphyt in “Référence Agro” : “Evaluation of phytosanitary solutions, Staphyt’s view”
5 May 2022

Référence Agro – Gaëlle Gaudin – April 28, 2022 Risk assessment, Biocontrol solutions Staphyt, which…

+ Read more

Référence Agro – Gaëlle GaudinApril 28, 2022 Risk assessment, Biocontrol solutions

Staphyt, which has been supporting crop protection companies for more than thirty years in the development and marketing of active substances and products, reviews for Référence agro the changes observed in recent years. The tightening of conventional products evaluations and the rise of biosolutions are at the heart of his work. Meeting with Amélie Grimaldi and Geoffroy Moulin, respectively in charge of regulatory affairs and coordinator of biological expertise for the company.

For thirty years, Staphyt has been involved in the development of plant protection products, risk assessment, and the preparation of registration dossiers for substances and products to be marketed throughout Europe. Staphyt has been able to observe the gradual evolution towards less chemical plant protection specialities and the evolution of dedicated regulations.

Rise of startups since 2017

“We work with a large number of players in the industry, from preliminary laboratory screening work to the marketing of the plant protection product,” says Geoffroy Moulin, biosolutions coordinator for the company. The first biocontrol product we dealt with was in 2006. But since 2017, we have seen the rise of startups in biosolutions and for the past three years, the massive arrival of conventional industrials on these alternative solutions. The sponsors of the latest editions of ABIM, the annual meetings of the biocontrol industry, are proof of this. These agrochemists are developing their product portfolio through partnerships with these startups. And vice versa: a large number of startups approach these large companies every year.”

Amélie Grimaldi, head of regulatory affairs, is supported by toxicologists, ecotoxicologists, environmental experts, chemists, residue specialists and agronomists. The division has a total of 70 employees out of Staphyt’s 240 in France. Obtaining the regulatory data required for the approval of a substance or the marketing authorization of a speciality requires all these skills,” explains the manager. But startups do not have a regulatory department, or not as complete. As for large companies, they call on us when they have to deal with peaks in workload.

Because putting together a regulatory dossier is time consuming. “We count more than a thousand hours of work to re-evaluate a single product in the three European Union zones, following the renewal of an active substance,” says Amélie Grimaldi.

The renewal of an active substance requires more work than in the past because of the increased requirements.

Reduction of the chemical load of the products

The number of conventional active substances approved at European level is falling, but chemistry is still dominant. At Staphyt, many dossiers concern reformulated conventional products. “We often have to reduce the authorized doses compared to what was accepted ten years ago,” notes Geoffroy Moulin.

Ten years ago, Staphyt set up a team of agronomists, scientists and regulatory experts to study biosolutions. Because biosolutions are on the rise and require a distinct technical and regulatory approach.

Over the past three years, the number of low-risk substances approved at the European level has doubled, the number of micro-organisms has also almost doubled and the number of natural substances has tripled.

“The share of biocontrol in our turnover has doubled in the last four years,” Geoffroy Moulin reports.

Biopesticides boosted by numerous advantages

Biopesticides are growing rapidly because of the advantages they represent,” adds Amélie Grimaldi. The cost of a dossier is lower, particularly because the number of studies is lower, as the substance is automatically eliminated if it presents a risk, apart from its irritant nature. For the approval of a biological active substance, it is necessary to count 2 M€, against sometimes 10 M€ for a conventional substance. Development and evaluation times are also shortened and approval periods are lengthened. Finally, these alternative specialties benefit from political support, both at the European and national levels.

Proving the effectiveness of a biopesticide is difficult

However, the regulatory manager is keen to temper these advantages. It’s not always easy to put together dossiers because the requirements, guidance documents and risk assessment are not all well adapted to these specialties,” she says. In addition, national regulations differ, which makes registration in Europe more complex. It is also more difficult to accurately characterize the substance of a biopesticide and prove its efficacy. Finally, while the cost of risk assessment is lower for these specialties, the cost to find the optimal positioning, as well as the cost of marketing support, are more substantial.

Conventional agrochemists work on solutions that combine conventional and biosolutions. “The trial programs for such combined solutions are gaining momentum,” says Amélie Grimaldi.

Link to the article:

In 2021, Staphyt joins University of Tasmania to research organic products and treatments in the fight against bluberry rust. In 2022, Staphyt teams keep going field trials in New South Wales to evaluate a range of organic crop protectants which are not yet approved for use in blueberry against rust. Staphyt contributes also in the workshop set up to allow growers to practice monitoring for disease and tackle a hypothetical but realistic scenario of finding blueberry rust symptoms in their orchard.

Read more about:

Staphyt has just joined the Research and Innovation Consortium PlantAlliance that brings together about 30 public and private members which focus on the contribution of genetics, genomics and plant biology to the design of innovative agro-ecological cropping systems.

The objective of this consortium is to offer plant species and varieties that meet the challenges of agricultural sustainability and are adapted to a diversity of cropping systems and production methods.

The approval of Staphyt candidature by all the professionals present in this community is a recognition of our know-how and expertise in plant breeding and seeds activity.

Participation in the working groups will enable us to keep abreast of technological and agronomic advances as well as regulatory developments in this field. We are very proud to join this consortium.

Pascal Basta and Jeanne Salé will represent Staphyt within Plant Alliance.

 More information about Consortium PlantAlliance:

Last June, Staphyt’s application to join the Biocontrôle Consortium was selected and we are proud and happy to be increasingly involved in the development of biocontrols.

This consortium, bringing together nearly 60 public research actors, institutes and private developers of innovative solutions, was created in 2020 as part of the French national strategy for the deployment of biocontrol, co-led by the Ministry of Agriculture and of Food and by the Ministry of Ecological Transition. Its mission is to support and promote biocontrol through research and innovation, by creating new tools for monitoring the performance and efficacy of these products. The development of biocontrol solutions requires a better understanding of their mode of action in various agronomic contexts.

In France, biocontrol solutions represent more than 12% of the plant protection market. The Biocontrôle Consortium is one of the tools enabling IBMA France to achieve its ambition: by 2023 to increase the share of this sector to 15% of the French crop protection market and to 30% in France. horizon 2030.

Our technical and scientific teams will participate in discussions and working groups to develop new research themes and deepen existing knowledge on biocontrol products.

For any questions about this ambitious project, do not hesitate to contact Frédéric GIRAUD, Staphyt representative within the consortium.

More information: